Comparing medications in a therapeutic area using an NNT model

Area of Science:

• Clinical Epidemiology
• Biostatistics
• Evidence-Based Medicine

Background:

• The number needed to treat (NNT) is a standard metric for comparing therapeutic benefits.
• Current NNT calculations often overlook critical differences in study design and population.
• This variability can lead to misleading comparisons of treatment efficacy.

Purpose of the Study:

• To compare crude NNT values with those standardized for common outcomes, follow-up times, populations, and comparators.
• To introduce and demonstrate an NNT model for cardiovascular disease secondary prevention.
• To highlight the impact of standardization on NNT variability and interpretation.

Main Methods:

• Compared unadjusted NNTs with NNTs standardized across key study parameters.
• Developed and applied a specific NNT model for secondary cardiovascular disease prevention.
• Analyzed 18 relevant clinical trials with varying follow-up durations and event rates.

Main Results:

• Trial follow-up ranged from 1.0 to 6.2 years; cardiovascular event rates varied from 4.8% to 45.9%.
• Crude NNTs showed greater variability (9.1-163.7) compared to the standardized model (9.1-75.2).
• Standardization significantly altered NNTs, with changes from a 91% decrease to a 223% increase.

Conclusions:

• An NNT model that standardizes for study design differences enables more meaningful comparisons.
• This approach enhances the reliability of NNT values in evidence-based clinical decision-making.
• The proposed model is particularly valuable for comparing interventions in cardiovascular disease secondary prevention.